PATENT APPLICATIONS AND PATENTS Clause Samples

The "Patent Applications and Patents" clause defines the rights and responsibilities of the parties regarding the filing, ownership, and management of patent applications and granted patents arising from their relationship. Typically, this clause outlines which party has the authority to file patent applications, how costs are shared, and how inventions are disclosed and protected. For example, it may specify that inventions developed jointly will be co-owned, or that one party will handle prosecution while keeping the other informed. The core function of this clause is to prevent disputes over intellectual property by clearly allocating rights and obligations related to patents, ensuring both parties understand their roles in protecting and benefiting from innovations.
POPULAR SAMPLE Copied 1 times
PATENT APPLICATIONS AND PATENTS. Upon request of Licensee, Caltech shall disclose and deliver to Licensee copies of all patent applications and issued patents within the Exclusively Licensed Patent Rights and Improvement Patent Rights.
PATENT APPLICATIONS AND PATENTS. 5.1 The parties hereto agree that Licensor’s consultant, ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇, shall hold the entire right, title, and interest in and to the Patent Rights and Know-How, and Licensee agrees to perform all acts and to execute, acknowledge and deliver all instruments or writings reasonably requested and necessary for ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ to perfect title to the Patent Rights and Know-How. ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ shall ▇▇▇▇▇ an exclusive license of the Patent Rights and Know-How to Licensor who shall grant rights and licenses in the Patent Rights and Know-How to Licensee. 5.2 The parties hereto agree that they will procure Patent Rights on the Licensed Products. Licensor shall have the sole right to prosecute, control, and pursue such Patent Rights under the patent laws of the United States and foreign countries. Licensor agrees to prosecute, with good faith and due diligence, all pending and future patent applications. All fees, costs and expenses shall be borne by Licensee. Licensee agrees to cooperate with Licensor to whatever extent is necessary to procure such patent protection. 5.3 In the event Licensee decides to abandon any pending United States or foreign patent application or to not pay any annuity or maintenance fee required by any country, Licensee shall give Licensor thirty (30) days prior written notice of such decision and shall allow Licensee to become the owner of such United States or foreign patent or application and to pay such fee. Licensee’s decision shall have no effect on the Royalties. 5.4 Licensor agrees to keep Licensee fully informed, at Licensee’s expense, of the prosecution of all U.S. and foreign patent applications including submitting to the Licensee copies of all official actions and responses thereto. 5.5 Licensee shall have the right to conduct an audit of the Patent Rights to ensure that the Patent Rights are in good standing and that Licensor has maintained them in good standing during the term of this License Agreement. In the event that Licensee determines that the Patent Rights are not in good standing, then Licensee shall have the right to place such Patent Rights in good standing and if necessary, to seek relief through binding mediation and arbitration pursuant to Article XII if the failure to maintain the Patent Rights in good standing may cause or has caused the Licensee damages. 5.6 Licensee agrees to comply with any marking requirements of Licensor to insure compliance with 35 U.S.C. § 287, and agrees to insure complianc...
PATENT APPLICATIONS AND PATENTS. The patent applications and patents listed in Section Appendix A below and any of the following relating to such patents or patent applications: (a) corresponding applications and patents claiming priority from any one or more of those patents and patent applications filed in any country in the Territory; (b) patents and any special protection certificates that are issued on the applications listed below; (c) divisions, continuations, continuations-in-part, reissues, re-examinations, registrations, divisional and substituted patents from the patents and patent applications listed below; (d) additions, counterparts or extensions; and (e) any granted patents resulting from the patent applications listed below.
PATENT APPLICATIONS AND PATENTS. To the extent LICENSEE determines that one or more aspects of the Devices are patentable, LICENSEE shall file and prosecute or cause to be filed and prosecuted one or more applications for a United States patent or patents covering one or more aspect of the Devices. LICENSEE shall have the right to file and prosecute or cause to be filed and prosecuted one or more applications for a foreign patent or patents covering one or more aspects of the Devices. COMPANY shall be shown as an inventor of record on all such United States and foreign patent applications and all United States and foreign patents issued thereon shall be subject to the Patent License Agreement entered into by the COMPANY and the LICENSEE concurrently herewith. All costs and expenses relating to, and the control of (including, without limitation, matters relating to filing, prosecution, reissue, reexamination and withdrawal) such patent applications shall be the exclusive responsibility of LICENSEE in its sole and absolute discretion.
PATENT APPLICATIONS AND PATENTS. To the extent LICENSEE determines that one or more aspects of the Devices are patentable, LICENSEE shall file and prosecute or cause to be filed and prosecuted one or more applications for a United States patent or patents covering one or more aspects of the Devices. LICENSEE shall have the right to file and prosecute or cause to be filed and prosecuted one or more applications for a foreign patent or patents covering one or more aspects of the Devices. COMPANY shall be shown as the assignee of record on all such United State and foreign patent applications and all United States and foreign patents issued thereon shall be subject to the Patent License Agreement entered into by the COMPANY and the LICENSEE concurrently herewith. All costs and expenses relating to, and the control of (including, without limitation, matters relating to filing, prosecution, reissue, reexamination and withdrawal) such patent applications shall be the exclusive responsibility of LICENSEE in its sole and absolute discretion. If LICENSEE does not timely pursue a patent or patents on a new invention arising under the technology licensed under this Agreement, COMPANY shall have the option to pursue such patent or patents at its own expense and such derived patent or patents shall not be subject to the licensure under this Agreement.
PATENT APPLICATIONS AND PATENTS. 4.1 The parties hereto agree that Licensor shall hold the entire right, title, and interest in and to the Patent Rights and Know-How, and Licensee agrees to perform all acts and to execute, acknowledge and deliver all instruments or writings reasonably requested and necessary for Licensor to perfect title to the Patent Rights and Know-How. Licensor hereby grants an exclusive license of the Patent Rights and Know-How to Licensee pursuant to Paragraph 2.1. 4.2 The parties hereto agree that they will procure Patent Rights on the Licensed Products. Licensor shall have the sole right to prosecute, control, and pursue such Patent Rights under the patent laws of the United States and foreign countries. Licensor agrees to prosecute, with good faith and due diligence, all pending and future patent applications. All fees, costs and expenses shall be borne by Licensee. Licensee agrees to cooperate with Licensor to whatever extent is necessary to procure such patent protection. 4.3 In the event Licensee decides to abandon any pending United States or foreign patent application or to not pay any annuity or maintenance fee required by any country, Licensee shall give Licensor thirty (30) days prior written notice of such decision and shall allow Licensor to pay such fee. Licensee’s decision shall have no effect on the Royalties. 4.4 Licensor agrees to keep Licensee fully informed, at Licensee’s expense, of the prosecution of all U.S. and foreign patent applications including submitting to the Licensee copies of all official actions and responses thereto. 4.5 Licensee agrees to comply with any marking requirements of Licensor to insure compliance with 35 U.S.C. § 287, and agrees to insure compliance by its sublicensees, if any.
PATENT APPLICATIONS AND PATENTS. 5.1 The parties hereto agree that ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ shall hold the entire right, tide, and interest in and to the Algae Biomass Technology, including Improvements, to the Algae Biomass Technology and Intellectual Property, and Licensee agrees to perform all acts and to execute, acknowledge and deliver all instruments or writings reasonably requested and necessary for ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ to perfect title to the Algae Biomass Technology and Intellectual Property. 5.2 Licensor and Licensee agree that they will procure Patent Rights on the Algae Biomass Technology and Improvements. Licensor shall have the sole right to prosecute, control, and pursue such Patent Rights under the patent laws of the United States and foreign countries. Licensor agrees to prosecute, with good faith and due diligence, all pending and future patent applications. All fees, costs and expenses shall be borne by Licensee and the failure of Licensee to pay such fees, costs and expenses shall constitute a substantial breach of this License Agreement. Licensee agrees to cooperate with Licensor to whatever extent is necessary to procure such patent protection. 5.3 In the event Licensor decides to abandon any pending United States or foreign patent application or to not pay any annuity or maintenance fee required by any country, Licensor shall give Licensee thirty (30) days prior written notice of such decision and shall allow Licensee to become the owner of such United States or foreign patent or application and to pay such fee. Licensee's decision shall have no effect on the Royalties.
PATENT APPLICATIONS AND PATENTS. University will notify LCCMR in the event that a provisional application is filed with the US Patent and Trademark Office from an invention disclosure that lists LCCMR as a funding source. University will also notify LCCMR upon the filing of subsequent applications claiming priority to such provisional applications. Upon request, University will supply LCCMR with copies of all such provisional and other applications and patents that issue from these applications as they are filed and if they proceed to issue or grant. LCCMR agrees that such applications are to be treated as confidential information until such time as all the information in the applications has been made public.
PATENT APPLICATIONS AND PATENTS 

Related to PATENT APPLICATIONS AND PATENTS

  • Patents and Patent Applications To the Company’s knowledge, all patents and patent applications owned by or licensed to the Company or under which the Company has rights have been duly and properly filed and maintained; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the USPTO in connection with such applications; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which could reasonably be expected to preclude the grant of a patent in connection with any such application or could reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect to such applications.

  • Patent Applications It is understood by the parties that, pursuant to the Baylor Technology Transfer Agreement, MAS has the initial responsibility for filing, prosecution and maintenance of Patents and Patent Applications covering the Baylor Technology. The parties agree that, as between MAS and IllumeSys, MAS shall be responsible for deciding whether and how to file, prosecute and maintain the Patents and Patent Applications, provided that:

  • Inventions and Patents For purposes of this Agreement, “Inventions” includes, without limitation, information, inventions, contributions, improvements, ideas, or discoveries, whether protectable or not, and whether or not conceived or made during work hours. Executive agrees that all Inventions conceived or made by Executive during the period of employment with Employer belong to Employer, provided they grow out of Executive’s work with Employer or are related in some manner to the Business, including, without limitation, research and product development, and projected business of Employer or its affiliated companies. Accordingly, Executive will: a. Make adequate written records of such Inventions, which records will be Employer’s property; b. Assign to Employer, at its request, any rights Executive may have to such Inventions for the U.S. and all foreign countries; c. Waive and agree not to assert any moral rights Executive may have or acquire in any Inventions and agree to provide written waivers from time to time as requested by Employer; and d. Assist Employer (at Employer’s expense) in obtaining and maintaining patents or copyright registrations with respect to such Inventions. Executive understands and agrees that Employer or its designee will determine, in its sole and absolute discretion, whether an application for patent will be filed on any Invention that is the exclusive property of Employer, as set forth above, and whether such an application will be abandoned prior to issuance of a patent. Employer will pay to Executive, either during or after the term of this Agreement, the following amounts if Executive is sole inventor, or Executive’s proportionate share if Executive is joint inventor: $750 upon filing of the initial application for patent on such Invention; and $1,500 upon issuance of a patent resulting from such initial patent application, provided Executive is named as an inventor in the patent. Executive further agrees that Executive will promptly disclose in writing to Employer during the term of Executive’s employment and for one (1) year thereafter, all Inventions whether developed during the time of such employment or thereafter (whether or not Employer has rights in such Inventions) so that Executive’s rights and Employer’s rights in such Inventions can be determined. Except as set forth on the initialed Exhibit B (List of Inventions) to this Agreement, if any, Executive represents and warrants that Executive has no Inventions, software, writings or other works of authorship useful to Employer in the normal course of the Business, which were conceived, made or written prior to the date of this Agreement and which are excluded from the operation of this Agreement.

  • Patent The development of patentable inventions or discoveries is not the primary purpose of the research activities of the faculty. Employees have no obligation to seek patent protection for the results of scientific work nor to modify research to enhance patentability. 10.6.1 OC agrees that employees have the unqualified right to publish their inventions, improvements, designs or developments and, except as noted in section 10.6.3, OC waives, disclaims and abandons any interest in or claims to any invention, improvement, design or development made by an employee or employees and unless otherwise provided in this Article, any invention, improvement design or development, or any patent arising therefrom shall be the sole property of the inventor(s). 10.6.2 Where the activities are a part of work performed for which OC is not paying the employee from any source and no OC space or equipment is being used, the employee shall be entitled to any and all royalties from such patents. Employees shall have the right to make their own arrangements at their own expense to patent an invention, an improvement, a design or development and, subject to the obligations in the Article and except as noted in section 10.6.3, shall be entitled to all the proceeds therefrom.

  • Filing of Patent Applications Each Party will make timely decisions regarding the filing of Patent Applications on the CRADA Subject Inventions made solely by its employee(s), and will notify the other Party in advance of filing. Collaborator will have the first opportunity to file a Patent Application on joint CRADA Subject Inventions and will notify PHS of its decision within sixty (60) days of an Invention being reported or at least thirty (30) days before any patent filing deadline, whichever occurs sooner. If Collaborator fails to notify PHS of its decision within that time period or notifies PHS of its decision not to file a Patent Application, then PHS has the right to file a Patent Application on the joint CRADA Subject Invention. Neither Party will be obligated to file a Patent Application. Collaborator will place the following statement in any Patent Application it files on a CRADA Subject Invention: “This invention was created in the performance of a Cooperative Research and Development Agreement with the [INSERT into Agency’s model as appropriate: National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention], an Agency of the Department of Health and Human Services. The Government of the United States has certain rights in this invention.” If either Party files a Patent Application on a joint CRADA Subject Invention, then the filing Party will include a statement within the Patent Application that clearly identifies the Parties and states that the joint CRADA Subject Invention was made under this CRADA.